Precision Biosensor, Inc. (KOSDAQ: 335810)
South Korea
· Delayed Price · Currency is KRW
2,920.00
-15.00 (-0.51%)
Dec 19, 2024, 2:08 PM KST
Precision Biosensor Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Operating Revenue | 18,215 | 20,391 | 20,458 | 15,887 | 8,685 | 6,205 | Upgrade
|
Other Revenue | - | - | - | -0 | - | - | Upgrade
|
Revenue | 18,215 | 20,391 | 20,458 | 15,887 | 8,685 | 6,205 | Upgrade
|
Revenue Growth (YoY) | -11.45% | -0.33% | 28.77% | 82.93% | 39.97% | 35.23% | Upgrade
|
Cost of Revenue | 12,941 | 12,705 | 13,703 | 11,282 | 3,918 | 3,432 | Upgrade
|
Gross Profit | 5,275 | 7,686 | 6,755 | 4,605 | 4,767 | 2,772 | Upgrade
|
Selling, General & Admin | 6,593 | 7,288 | 7,437 | 6,303 | 3,783 | 3,132 | Upgrade
|
Research & Development | 3,707 | 3,196 | 2,611 | 1,958 | 2,045 | 1,665 | Upgrade
|
Other Operating Expenses | 240.93 | 249.05 | 231.68 | 243.58 | 230.47 | 243.15 | Upgrade
|
Operating Expenses | 12,379 | 12,496 | 11,255 | 8,874 | 6,485 | 5,409 | Upgrade
|
Operating Income | -7,104 | -4,811 | -4,500 | -4,269 | -1,719 | -2,636 | Upgrade
|
Interest Expense | -2,083 | -1,230 | -816.95 | -162.1 | -23.57 | -17.83 | Upgrade
|
Interest & Investment Income | 186.25 | 188.19 | 187.26 | 70.52 | 71.82 | 72.99 | Upgrade
|
Currency Exchange Gain (Loss) | 140.75 | 196.85 | 254.17 | 285.95 | -142.3 | 105.9 | Upgrade
|
Other Non Operating Income (Expenses) | -303.28 | -172.23 | -2,273 | -254.15 | -2,997 | 2,071 | Upgrade
|
EBT Excluding Unusual Items | -9,163 | -5,827 | -7,148 | -4,329 | -4,810 | -404.76 | Upgrade
|
Gain (Loss) on Sale of Investments | 33.75 | 90.06 | 137.79 | 48.66 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 3.01 | - | 5.27 | 0.03 | -142.71 | - | Upgrade
|
Other Unusual Items | 416.82 | 354.95 | - | - | - | - | Upgrade
|
Pretax Income | -8,709 | -5,382 | -7,005 | -4,281 | -4,953 | -404.76 | Upgrade
|
Income Tax Expense | -700.72 | -892.03 | -199.36 | -128.31 | 0.3 | 0.58 | Upgrade
|
Net Income | -8,009 | -4,490 | -6,806 | -4,152 | -4,953 | -405.34 | Upgrade
|
Net Income to Common | -8,009 | -4,490 | -6,806 | -4,152 | -4,953 | -405.34 | Upgrade
|
Shares Outstanding (Basic) | 12 | 12 | 12 | 11 | 9 | 7 | Upgrade
|
Shares Outstanding (Diluted) | 12 | 12 | 12 | 11 | 9 | 7 | Upgrade
|
Shares Change (YoY) | 0.17% | 0.67% | 2.10% | 25.37% | 24.75% | 15.37% | Upgrade
|
EPS (Basic) | -689.53 | -386.98 | -590.47 | -367.80 | -550.04 | -56.16 | Upgrade
|
EPS (Diluted) | -689.87 | -387.00 | -590.47 | -368.00 | -550.04 | -56.16 | Upgrade
|
Free Cash Flow | -2,107 | -9,006 | -13,719 | -13,726 | -6,950 | -2,344 | Upgrade
|
Free Cash Flow Per Share | -181.45 | -776.13 | -1190.18 | -1215.81 | -771.85 | -324.77 | Upgrade
|
Gross Margin | 28.96% | 37.69% | 33.02% | 28.98% | 54.89% | 44.68% | Upgrade
|
Operating Margin | -39.00% | -23.59% | -22.00% | -26.87% | -19.79% | -42.49% | Upgrade
|
Profit Margin | -43.97% | -22.02% | -33.27% | -26.14% | -57.03% | -6.53% | Upgrade
|
Free Cash Flow Margin | -11.57% | -44.17% | -67.06% | -86.40% | -80.03% | -37.78% | Upgrade
|
EBITDA | -3,643 | -1,665 | -2,218 | -3,091 | -948.01 | -1,881 | Upgrade
|
EBITDA Margin | -20.00% | -8.17% | -10.84% | -19.45% | -10.92% | -30.31% | Upgrade
|
D&A For EBITDA | 3,461 | 3,145 | 2,282 | 1,179 | 770.51 | 755.84 | Upgrade
|
EBIT | -7,104 | -4,811 | -4,500 | -4,269 | -1,719 | -2,636 | Upgrade
|
EBIT Margin | -39.00% | -23.59% | -22.00% | -26.87% | -19.79% | -42.49% | Upgrade
|
Advertising Expenses | - | 200 | 76.59 | 108.79 | 30.48 | 82.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.